Bioactivity | ALW-II-49-7 is a selective EphB2 kinase inhibitor with an EC50 value of 40 nM in cell[1]. | ||||||||||||
Target | EphB2 | ||||||||||||
Invitro | ALW-II-49-7 (化合物 9) 对一些激酶具有选择性,包括结合 b-raf, CSF1R,DDR1,DDR2,EphA2,EphA5,EphA8,EphB1,EphB2,EphB3,Frk,Kit,Lck,p38a,p38b,PDGFRa,PDGFRb 和 Raf1[1]。ALW-II-49-7 (0.01-10 μM; 1 h) 抑制 U87 胶质母细胞瘤细胞中 EphB2 激酶的活力,EphB2 的添加浓度为 2 μg/mL[1]。 | ||||||||||||
Name | ALW-II-49-7 | ||||||||||||
CAS | 1135219-23-6 | ||||||||||||
Formula | C21H17F3N4O2 | ||||||||||||
Molar Mass | 414.38 | ||||||||||||
Appearance | Solid | ||||||||||||
Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
Storage |
|
||||||||||||
Reference | [1]. Choi Y, et al. Discovery and structural analysis of Eph receptor tyrosine kinase inhibitors. Bioorg Med Chem Lett. 2009 Aug 1;19(15):4467-70. |